MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Trail Making Task in people with isolated REM sleep behaviour disorder

    H. Chohan, T. Periñán, S. Waters, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: This study aimed to evaluate online remote executive function in individuals with isolated polysomnography (PSG)-confirmed REM sleep behaviour disorder (iRBD). Background: The Trail Making…
  • 2025 International Congress

    Single-Center Real-World Validation of Cognitive vs. Motor-Based Fall Prediction Models in Parkinson’s Disease

    S. Anis, E. Zimmerman, H. Fernandez, A. Rosenfeldt, J. Alberts (Cleveland, USA)

    Objective: This study aimed to evaluate the performance of our previously developed cognitive-based fall prediction model (Anis et al. 2025) in a real-world setting using…
  • 2025 International Congress

    Advancing MDS Guidelines for Electronic Clinical Outcome Assessments: Best Practices for Validation and Implementation

    R. Fuller, M. Skorvanek, M. Monje, M. Tosin, S. Ali, A. Lofald, A. Sanchez Ferro, T. Mestre (Princeton, USA)

    Objective: To update and formalize the International Parkinson and Movement Disorder Society (MDS) Clinical Outcomes Assessment Program guidelines on validating and evaluating electronic clinical outcome…
  • 2025 International Congress

    Falls in Parkinson Disease, Videonystagmography and Fear of Falls – an Exploratory Study.

    I. Monteiro, M. Salmito, K. Aguiar, F. Rolim, M. Rela, A. Ferreira Gomes, F. Carvalho (Fortaleza, Brazil)

    Objective: To investigate findings on ocular motility, fear of falling and functionality in two patients with Parkinson’s Disease (PD) from Brazil. Background: PD impaires motor…
  • 2025 International Congress

    Refining the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

    M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

    Objective: To assess the face and content validity of the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS), a new under-developing Clinical…
  • 2025 International Congress

    Long-Term Effects of Telerehabilitation on Functional Mobility and Quality of Life in Parkinson’s Disease: A Systematic Review

    A. Elsayed, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. M. Elsayed (Mansoura, Egypt)

    Objective: To evaluate the long-term effects of telerehabilitation on functional mobility and quality of life (QoL) in individuals with Parkinson’s disease (PD) and determine its…
  • 2025 International Congress

    Efficacy of Rifaximin as an Adjunct Treatment for Levodopa induced dyskinesia: Preliminary Results

    K. Salinas-Barboza, J. Altamirano, L. Navarro-Roa, M. Rodriguez-Violante (Ciudad de México, Mexico)

    Objective: To evaluate the efficacy of rifaximin as an adjunct treatment for LID (levodopa induced dyskinesia) in patients with PD through a randomized, double-blind, placebo-controlled…
  • 2025 International Congress

    Validation of a quantitative test using kinesiological evaluation of upper extremity movements in patients with Parkinson’s disease: A pilot study.

    A. Castillo-Ivon, A. Montes-Ugalde, V. Bueyes-Roiz, C. Hernandez-Arenas, P. Velasco-Acosta, L. Anaya-Campos, I. Quiñones-Uriostegui, J. Quinzaños-Fresnedo (Mexico City, Mexico)

    Objective: To establish the validity of an upper extremity kinesiological assessment in patients with Parkinson's disease as a complementary tool to clinical instruments. Background: Parkinson's…
  • 2025 International Congress

    Characteristics and Trends of Parkinson’s Disease Patients Receiving Deep Brain Stimulation: Insights From a US All-Payer Health Administrative Claims Database

    W. Zhang, M. Bharadwaz, A. Gabriel, J. Weber, M. Frick, A. Yaldo, C. Gøtzsche, T. Machewitz, J. Lott (Whippany, USA)

    Objective: To describe sociodemographics, treatment patterns, and costs among Parkinson’s patients who received deep brain stimulation (DBS) in the United States (US). Background: Parkinson’s disease…
  • 2025 International Congress

    Prevalence of Central Pain in Parkinson’s Disease: A Systematic Review and Meta-analysis

    K. Vieira, L. Pereira, G. Trevisan (Santa Maria, Brazil)

    Objective: In this systematic review and meta-analysis, we aimed to evaluate the prevalence of central pain and how this symptom may affect the patient's quality…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley